Riskpilot← Back to searchSign inGet full accessMedest Scandinavia AB
ABIn liquidationOrg 5565924247FalunWholesale of pharmaceutical and medical goods · NACE 4646Est. 20000 employees
Revenue 2024
SEK 731K
+7% vs 2023
EBITDA margin
-8.9%
-108% vs 2023
Equity ratio
12.9%
Financial strength
Net profit 2024
SEK 16K
+633% vs 2023
| Revenue | SEK 731K | +7% |
| EBITDA | SEK -65K | -108% |
| Net profit | SEK 16K | +633% |
| Total assets | SEK 1,3M | -37% |
| Equity | SEK 168K | +11% |
| Employees | 0 | — |
Legal name
Medest Scandinavia AB
Org number
5565924247
Legal form
Aktiebolag
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
25 maj 2000
Share capital
SEK 100 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas var för sig av likvidatorn externa firmatecknarna
Company purpose
Bolaget skall bedriva utbildnings- och konsultverksamhet inom områdena räddningstjänst, sjukvård, säkerhet och kemikalie- hantering samt bedriva utveckling, produktion och marknadsföring av produkter inom dessa områden ävensom idka därmed förenlig verksamhet.
Address
Falun
Phone
+4669120140
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 1 092 | 1 118 | 1 166 | 684 | 731 |
| Staff expenses | — | — | — | — | — |
| EBITDA | −2 | 25 | 67 | 775 | −65 |
| Depreciation & amort. | −23 | −23 | −23 | −20 | −0 |
| EBIT | −25 | 2 | 44 | 755 | −65 |
| Net financials | −4 | −3 | −4 403 | 2 | 30 |
| Profit before tax | 56 | −7 | −2 230 | −3 | 16 |
| Tax | −13 | −1 | −0 | −0 | −0 |
| Net profit | 43 | −8 | −2 230 | −3 | 16 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 4 088 | 3 871 | 1 672 | 2 060 | 1 302 |
| Equity | 2 392 | 2 385 | 155 | 152 | 168 |
| Long-term debt | 600 | 600 | 600 | 600 | 0 |
| Short-term debt | 636 | 522 | 681 | 1 113 | 1 089 |
| Total debt | 1 236 | 1 122 | 1 281 | 1 713 | 1 089 |
EBITDA margin
-8.9%
This company
15.8%
Market median
-156% vs market
20202024
Equity ratio
12.9%
This company
38.2%
Market median
-66% vs market
20202024
Return on equity
9.5%
This company
18.4%
Market median
-48% vs market
20202024
Net profit margin
2.2%
This company
8.1%
Market median
-73% vs market
20202024
Asset turnover
0.56×
This company
1.12×
Market median
-50% vs market
20202024
Debt / equity
6.75×
This company
0.62×
Market median
-989% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (5) | ||
LB External Signatory | External Signatory | 2025 |
BJ External Signatory | External Signatory | 2025 |
AE External Signatory | External Signatory | 2025 |
UM External Signatory | External Signatory | 2025 |
EJ Liquidator | Liquidator | 2025 |
| Former (2) | ||
KT | Audit | 2021 – 2024 |
CL Chief Executive Officer | Chief Executive Officer | 2021 – 2025 |
| Name | Role | Member since |
|---|---|---|
| Former (2) | ||
| Deputy Board Member | 2021 – 2022 | |
| Deputy Board Member | 2022 – 2025 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Medest Scandinavia AB 
Doctus Utbildning ABBoard members of Medest Scandinavia AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Lena Birgitta Killgren Jonsson | External Signatory | 0 companies |
| Bengt Junior Niklas Nygårds | External Signatory | 0 companies |
| Anna Elisabet Viktoria Björk | External Signatory | 0 companies |
| Karl Thomas Lundström | Audit | 0 companies |
| Ulrika Margareta Ahlholm | External Signatory | 0 companies |
| Curt Lennart Malmsten | Chief Executive Officer | 0 companies |
| Emma Johanna Karin Carlstedt Haga | Liquidator | 0 companies |
| Anna Margareta Malmsten | Deputy Board Member | 0 companies |
| John Carl-Olof Svensson | Deputy Board Member | 0 companies |